Home > Cardiology > Serum omega-3 fatty acids tied to improved STEMI prognosis

Serum omega-3 fatty acids tied to improved STEMI prognosis

Journal
Journal of the American College of Cardiology
Reuters Health - 26/10/2020 - Higher levels of serum omega-3 fatty acids at the time of ST-segment elevation myocardial infarction (STEMI) are associated with lower incidence of major adverse cardiovascular events (MACE) and all-cause mortality, a new study suggests. Researchers examined data on 944 consecutive STEMI patients who underwent primary percutaneous coronary interventions. After three years of follow-up, a total of 211 patients had MACE, 130 were readmitted for cardiovascular causes, and 108 died. At the time of STEMI, patients' mean proportion of omega-3 eicosapentaenoic acid (EPA) in serum phosphatidylcholine (PC) was 0.58 and the mean proportion of serum-PC alpha-linolenic acid (ALA) was 0.25. Both are measures of recent dietary consumption, the authors note in Journal of the American College of Cardiology. Each 1 standard deviation (SD) increase in serum-PC EPA was associated with a lower risk of MACE (hazard ratio 0.76) and cardiovascular read...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on